CN Patent

CN101014321A — 5型磷酸二酯酶抑制剂的肺部给予

Assigned to Mannkind Corp · Expires 2007-08-08 · 19y expired

What this patent protects

本发明提供了1)5型磷酸二酯酶(PDE5)抑制剂的二酮哌嗪(DKP)盐和2)具有与其缔合的PDE5抑制剂的DKP颗粒的组合物，以及为了治疗肺高压和性功能障碍而将这些组合物给予到肺部的方法。

USPTO Abstract

本发明提供了1)5型磷酸二酯酶(PDE5)抑制剂的二酮哌嗪(DKP)盐和2)具有与其缔合的PDE5抑制剂的DKP颗粒的组合物，以及为了治疗肺高压和性功能障碍而将这些组合物给予到肺部的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101014321A
Jurisdiction
CN
Classification
—
Expires
2007-08-08
Drug substance claim
No
Drug product claim
No
Assignee
Mannkind Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.